Product Introduction:
Met XL Trio 25 Tablet combines three oral antidiabetic agents: Metformin (improves insulin sensitivity), Glimepiride (stimulates insulin secretion), and Pioglitazone (reduces insulin resistance). This triple combination helps in effective blood glucose control in type 2 diabetes patients.
Uses:
-
Management of type 2 diabetes mellitus
-
Control of high blood sugar levels when single or dual therapy is insufficient
Benefit:
-
Effective blood glucose reduction
-
Improved insulin sensitivity and secretion
-
Helps reduce HbA1c levels
-
Reduces risk of diabetes-related complications
-
Once daily dosing for better compliance
Composition:
Each tablet contains:
-
Metformin Hydrochloride Extended-Release IP – 1000 mg
-
Glimepiride IP – 2 mg
-
Pioglitazone Hydrochloride IP – 15 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal upset (nausea, diarrhea)
-
Weight gain
-
Edema (swelling)
-
Rare allergic reactions
Safety Advice:
-
Take with meals to reduce gastrointestinal side effects
-
Monitor blood sugar regularly to avoid hypoglycemia
-
Inform doctor if you have liver, kidney, or heart problems
-
Avoid alcohol while taking this medication
-
Do not stop or change dosage without medical advice
